Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 28:18:3745-3760.
doi: 10.2147/IDR.S522808. eCollection 2025.

Analyzing Shigella in Wuhan: Serotypes, Antimicrobial Resistance, and Public Health Implications

Affiliations

Analyzing Shigella in Wuhan: Serotypes, Antimicrobial Resistance, and Public Health Implications

Shiyong Deng et al. Infect Drug Resist. .

Abstract

Objective: This study aims to delineate the epidemiological characteristics and antibiotic resistance of Shigella flexneri isolates from Wuhan, focusing on serotype distribution, resistance patterns, and genetic diversity.

Methods: Our study analyzed 40Shigella flexneri isolates collected from 2011 to 2022 in Wuhan, assessing their serotype distribution and resistance to multiple antibiotics. We conducted resistance gene detection and genetic diversity analysis using polymerase chain reaction and pulsed-field gel electrophoresis (PFGE), respectively.

Results: The study revealed significant clustering of S. flexneri in the Jianghan and Dongxihu districts, with serotype 2a predominating. Isolates exhibited high resistance to ampicillin, tetracycline, and trimethoprim-sulfamethoxazole, with an overall multidrug resistance (MDR) rate of 67.5%. Serotypes 1b and 2b were fully sensitive, contrasting with higher resistance in serotypes 2a and 4a to fluoroquinolones. Resistance mechanisms included blaOXA and blaTEM for ampicillin, blaCTX-M for cephalosporins, tetB for tetracycline, and dfrA1 and sul2 for trimethoprim-sulfamethoxazole. All 12 quinolone-resistant isolates exhibited mutations in gyrA (S83L, D87N, D87G), parC (S80I), and parE (458A), and novel mutations were identified in gyrA (H221Y, A221V, A221E, I222N), parC (D197A), and parE (G408D). Pulsed-field gel electrophoresis (PFGE) analysis highlighted extensive genetic diversity with dominant groups P1 and P4, and with notable regional and temporal distribution patterns. Distinct PFGE types exhibited unique antimicrobial resistance profiles, with P1 and P4 showing high rates of multidrug resistance, while P5 and P3 displayed lower resistance levels. A notable evolutionary adaptation was observed in a clone from 2016 (P4-1), which by 2017 (P4-2) had acquired aminoglycoside resistance.

Conclusion: The study underscores the significant regional specificity and genetic diversity of S. flexneri in Wuhan, which poses challenges for treatment due to high antibiotic resistance and MDR prevalence. Findings stress the need for enhanced surveillance and tailored public health strategies to manage shigellosis effectively.

Keywords: Shigella flexneri; epidemiology; multidrug resistance; pulsed-field gel electrophoresis; resistance profile.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1
Figure 1
(A) Distribution of Shigella flexneri serotypes among isolates from different administrative districts in Wuhan (2011–2022). (B) Temporal trends of different serotypes of isolated Shigella flexneri strains.
Figure 2
Figure 2
Genetic mechanisms of antibiotic resistance in Shigella flexneri isolates.
Figure 3
Figure 3
PFGE pattern analysis of 40Shigella flexneri isolates from Wuhan.
Figure 4
Figure 4
The distribution of PFGE patterns of Shigella flexneri across different administrative districts in Wuhan.
Figure 5
Figure 5
A heatmap displaying the correlation between PFGE typing and antibiotic resistance rates of these Shigella flexneri isolates.

Similar articles

References

    1. Sansonetti PJ. Shigellosis: an old disease in new clothes? PLoS Med. 2006;3(9):e354. doi: 10.1371/journal.pmed.0030354 - DOI - PMC - PubMed
    1. DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis. 1989;159(6):1126–1128. doi: 10.1093/infdis/159.6.1126 - DOI - PubMed
    1. Zaidi MB, Estrada-Garcia T. Shigella: a highly virulent and elusive pathogen. Curr Trop Med Rep. 2014;1(2):81–87. doi: 10.1007/s40475-014-0019-6 - DOI - PMC - PubMed
    1. Pakbin B, Amani Z, Allahyari S, et al. Genetic diversity and antibiotic resistance of Shigella spp. isolates from food products. Food Sci Nutrition. 2021;9(11):6362–6371. doi: 10.1002/fsn3.2603 - DOI - PMC - PubMed
    1. Moxley RA. Enterobacteriaceae: shigella. Veterinary Microbiol. 2022;100–107.

LinkOut - more resources